Funding for this research was provided by:
Canadian Institutes of Health Research (200602MCT-1587547-RFA-CFC-100169)
National Institutes of Health (U54MD007584)
Article History
Received: 12 April 2018
Accepted: 18 October 2018
First Online: 1 November 2018
Ethics approval and consent to participate
: The QUARITE trial was approved by the following ethics committees: The National Council of Health Research in Senegal established under Ministerial order 3224 MSP-DERF-DE, the National Ethics Committee for the Health and Life Sciences of Mali under the Mali Ministry of Health established by Decree No. 02–200, and the Sainte-Justine Hospital (Montreal, Canada) Research Ethics Board as required under the Code Civil du Québec, RLRQ c CCQ-1991. Informed consent was obtained from local authorities at the participating hospitals and they were informed about the voluntary nature of the study and that they could withdraw at any point. Informed consent from individual patients was not required because hospitals authorized collection of clinical data from hospital registers and medical records.
: Not Applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.